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Abstract: In the last decade essential oils have attracted scientists with a constant increase rate of
more than 7% as witnessed by almost 5000 articles. Among the prominent studies essential oils
are investigated as antibacterial agents alone or in combination with known drugs. Minor studies
involved essential oil inspection as potential anticancer and antiviral natural remedies. In line with
the authors previous reports the investigation of an in-house library of extracted essential oils as
a potential blocker of HSV-1 infection is reported herein. A subset of essential oils was experimentally
tested in an in vitro model of HSV-1 infection and the determined IC50s and CC50s values were used in
conjunction with the results obtained by gas-chromatography/mass spectrometry chemical analysis to
derive machine learning based classification models trained with the partial least square discriminant
analysis algorithm. The internally validated models were thus applied on untested essential oils to
assess their effective predictive ability in selecting both active and low toxic samples. Five essential oils
were selected among a list of 52 and readily assayed for IC50 and CC50 determination. Interestingly,
four out of the five selected samples, compared with the potencies of the training set, returned to be
highly active and endowed with low toxicity. In particular, sample CJM1 from Calaminta nepeta was
the most potent tested essential oil with the highest selectivity index (IC50 = 0.063 mg/mL, SI > 47.5).
In conclusion, it was herein demonstrated how multidisciplinary applications involving machine
learning could represent a valuable tool in predicting the bioactivity of complex mixtures and in the
near future to enable the design of blended essential oil possibly endowed with higher potency and
lower toxicity.
Keywords: machine learning; classification modeling; essential oil; herpes simplex virus; PLS-DA;
quantitative composition-activity relationships; QCAR; multidisciplinary application
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1. Introduction
Essential oils (EOs) are natural complex aromatic-smelling mixture [1], deriving from plants’
secondary metabolism and containing predominately monoterpenes, sesquiterpenes and their
oxygenated derivatives. EOs are known to be biosynthesized in flowers, leaves, fruits and roots [2]
and are industrially produced mainly by hydro- [3] or steam-distillation [4].
Interests in the use of EOs in several fields is continuously increasing due to their biological
properties such as antioxidant or antimicrobial activities and many others [5–8]. Due to the EOs’
chemical composition complexity, recently challenges have been undertaken to discern the synergistic
and anti-synergistic roles of each single constituent and how they could influence the pharmacological
activities [9–11]. This categorization is even more complicated due to the ‘chemotype’ concept, in which
the same plant could produce different EOs’ chemical composition profiles and therefore different
biological properties [12,13]. Holy basil, thyme, lavender and peppermint are examples of plants with
several chemotypes [14]. Despite this hurdle, an effort to characterize EOs is currently undergoing
in medical and pharmaceutical fields, with the goal to obtain a clearer indication for their uses in
traditional medicine, chemical or pharmaceutical as witnessed by almost 5000 articles in the last decade
with an average positive increment of more than 7% per year (Figure 1).
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e e er e ce of novel drug-resistant microorganisms motivates the continuous search for
new therapeutic agents also in the natural world [15]. Among these, EOs are also c ntinuously
under investigation as potential new antiviral agents. EOs derived from Malaleuca alternifolia,
Mentha piperita and Thymus vulgaris as well as isolated essential oil com onents, were reported
to show antiviral properties, specifically against enveloped viruses [9]. In 2014 Civitelli et al. [16]
explored Mentha suaveolens EO (MSEO) effectiveness against herpes simplex virus type-1 (HSV-1)
replication in an in vitro model of infection. MSEO a d its main component, piperitenone oxide,
were found to reduce HSV-1 replication with IC50s of 0.0051 g/mL and 0.0014 mg/mL, respectively.
Very recently, Toujani et al. [17] demonstrated the antiviral properties of Thymus capitatus against
HSV-1 and herpes simplex virus type-2 (HSV-2), by testing three different phytopreparations (aqueous
extract (AE), ethanolic extract (EE) and EOs). Thymus capitatus phytopreparations AE, EE and EO were
analyzed by a gas chromatography/mass spectrometry (GC/MS) technique [10,15,18,19], identifying
β-sitosterol, cinnamaldehyde and carvacrol as the major chemical components. These three molecules
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were thus tested as pure compounds for their ability to inhibit the HSV-2 replication showing an EC50
of 0.0027, 0.0397 and 0.0519 mg/mL, respectively [17].
Multidisciplinary applications have been reported to successfully confirm the antiviral properties
of some medicinal plants extracts, including EOs as recently reported by Tariq et al. [20]. In this context,
the herein reported study was aimed at investigating the potential anti-HSV-1 activity on a series
of EOs to improve the knowledge about the antiviral effects of natural chemical mixtures. Hence,
a series of EOs derived from three different plants, Calamintha nepeta (CN) [18], Foeniculum vulgare
(FV) [19] and Ridolfia segetum (RS) [21], were considered. These EOs, extracted using the protocol by
Božovic´ et al. [18] and chemically characterized by GC/MS were herein tested in an in vitro model
of HSV-1 infection. Next, by means of principal component analysis (PCA) [22] and partial least
squares discriminant analysis (PLS-DA) [23], quantitative composition-activity relationships (QCAR)
models were developed and validated for their abilities in prediction to select further untested EOs for
improved antiviral and cytotoxic profile or possibly design blended EOs [24,25].
2. Results and Discussion
2.1. EOs’ Cytotoxic and Antiviral Effects
First, to check for cytotoxicity, Vero cells were incubated with different EO concentrations
(0.001–0.5 mg/mL) for 24 h and cell proliferation was measured by means of MTT assay (Figure 2).
Then the antiviral effect was evaluated in Vero cells infected with 0.1 m.o.i. of HSV-1 and exposed
soon after the virus-adsorption period (1 h) to various concentrations of each EO in a range of
0.0312–0.5 mg/mL for 24 h post-infection (p.i.; a representative ICW analysis is shown in Figure 1,
results in Table 1). With the only exception of samples 9 (FO24) and 35 (R6), all tested EOs
displayed CC50 values higher than IC50s, thus indicating that their effect on viral replication was
not affected by the cytotoxicities (Table 2). In particular, EOs from CN displayed the highest
antiviral potencies (IC50 range = 0.12–0.44 mg/mL, average = 0.22 mg/mL), the lowest cytotoxicity
(CC50 range = 1.10–4.71 mg/mL, average = 2.65 mg/mL) and the most favorable selectivity indexes
(SI range = 2.50–34.57, average = 13.87). Intermediate favorable profile was displayed by FVEOs
samples that had average values of IC50, CC50 and SI of 0.356, 1.24 and 4.7, respectively. Regarding the
four RSEO samples, they displayed the worst profile with good average IC50, but associated to high
cytotoxicity and thus low SI values.
Table 1. Cross-validation scores for the binary partial least squares discriminant analysis (PLS-DA)
classification models built with different IC50 cut-off values.
Statistical Parameter IC50-PLS-DA IC50-PLS-DA
cut-off (mg/mL) 0.25 0.20
EV 75% 75%
FNER 0.77 0.68
CVNER 0.71 0.61
ACC 0.76 0.68
EV: explained variance. FNER: fitting-non-error-rate. CVNER: cross-validation-non-error-rate. ACC: accuracy.
Table 2. Essential oils’ (EOs’) anti-HSV-1 (IC50), cytotoxicity (CC50) and selectivity index (SI) of the
tested EOs.
# a EO Id b IC50 (mg/mL) CC50 (mg/mL) SI # a EOs b IC50 (mg/mL) CC50 (mg/mL) SI
1 FA2 0.14 1.45 9.70 20 CS6 0.21 2.66 12.48
2 FA6 0.16 1.82 11.31 21 CO1 0.21 2.50 11.89
3 FS1 0.19 1.01 5.17 22 CO2 0.33 >3.00 >9.0
4 FS2 0.19 0.31 1.61 23 CO6 0.17 2.22 12.08
5 FS6 0.19 1.51 7.78 24 CJM2 0.33 2.50 7.60
6 FO1 0.72 1.50 2.07 25 CJM5 0.14 >3.00 >22.2
7 FO3 0.65 1.02 1.58 26 CAM1 0.20 2.65 13.11
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Table 2. Cont.
# a EO Id b IC50 (mg/mL) CC50 (mg/mL) SI # a EOs b IC50 (mg/mL) CC50 (mg/mL) SI
8 FO6 0.54 1.69 3.14 27 CAM3 0.15 2.99 19.50
9 FO24 0.58 0.36 0.61 28 CAM5 0.44 1.10 2.50
10 FOM3 0.18 1.7 9.63 29 CSM1 0.17 2.00 11.5
11 CJ1 0.27 2.15 7.87 30 CSM3 0.24 2.12 8.97
12 CJ2 0.14 >3.00 >22.2 31 CSM5 0.12 1.93 15.77
13 CA1 0.16 2.84 17.54 32 COM1 0.28 2.76 9.78
14 CA2 0.15 >3.00 >19.8 33 COM3 0.31 1.99 6.36
15 CA3 0.18 2.50 14.26 34 COM5 0.36 2.46 6.74
16 CA6 0.14 1.14 7.99 35 R6 0.43 0.41 0.94
17 CS1 0.14 2.50 17.82 36 R24 0.18 0.36 1.99
18 CS2 0.21 2.90 14.04 37 RM4 0.30 0.90 3.05
19 CS3 0.23 2.68 11.61 38 RM6 0.20 0.33 1.65
a # EO number. b EO’s Id refers to that reported in reference [10] published by the same authors of this reports.
SI = (CC50/IC50).
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Figure 2. In cell western (ICW) analysis of anti-HSV-1 effects of EO (68, CS12). 0. m.o i. HSV-1-infected
Vero c lls wer treated for 24 h with serial dilutions of EO 68 ranging from 0.0312 to 0.5 mg/mL. Untreated
HSV-1-infected cells (0 mg/mL EO) were used as comparativ control. Fixed cells were incubated with
anti-gB primary antibody and then with IRDye 800 CW secondary antibody (green fluorescence) and
CellTag 700 Stain (red fluorescence). HSV-1 is a mock infected cell (used as staining control).
2.2. Machine Learning Modeling
2.2.1. Unsupervised Data Analysis
PCA was used as an unsupervised technique to analyze and compare the 38 selected EOs
(Table 2). cumulative explain d variance of ab ut 76.54% was describ d by the first two PCs.
In partic lar, 63.17% of data bility was contained in the first PC, while 13.37% in the second PC.
A cumulative explained variance of 95% was obtained extract ng the third and fourth s (PC3 = 11.41%,
PC4 = 7.04%). As most of the v riance was conta ed in e first two PCs in pection was focused at
the respective score plot whose analysis revealed the pre ence of two distinct clu ters (Figure 3A).
FVEOs and RSEOs were grouped in a first most populated cluster, whereas the CNEOs constituted
a second one. The two clusters clearly indicated differences in the EOs chemical compositions and
at the same time also some resemblances among RSEOs and FVEOs samples. Analysis of PCA
loading plots (Figure 3B) revealed estragole, o-cymene, α-pinene and α-phellandrene as the chemical
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constituents mainly characterizing RSEOs and FVEOs cluster, while pulegone was mainly associated
to the CNEOs samples cluster. A further important chemical component emphasized by the PCA
loading plot (Figure 3B) was menthone, mainly associated to sample 32 (COM1) that seem to be of
peculiar composition so that this sample in the score plot is localized in a zone not comprised in neither
above clusters.
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2.2.2. Supervised Classification Modeling
Optimal cut-off values to divide the dependent data (IC50 and CC50), into active (A) and non-active
(NA), toxic (T) and non-toxic (NT) classes were established starting from the corresponding median
values (0.20 for the IC50 and 2.06 for the CC50), which were systematically modified applying an increase
or decrease of 5% to inspect for different cut-off boundaries. Cut-off values were inspected while
running leave one out cross validation (LOO-CV) while monitoring the explained variance (EV),
the fitting-non-error-rate (FNER), the cross-validation-non-error-rate (CVNER) and accuracy (ACC;
Table 1).
For IC50 values, the best PLS-DA classification model (IC50-PLS-DA) was obtained with a cut-off
of 0.15, while for CC50s (CC50-PLS-DA) the optimal cut-off was found to be 2.06 (Table 3).
Table 3. Cross-validation scores for the binary PLS-DA classification models built with different
cut-off values.
IC50-PLS-DA CC50-PLS-DA
cut-off (mg/mL) 0.15 2.06
ONPC 7 3
EV 98% 78%
FNER 0.97 1.00
CVNER 0.85 0.97
ACC 0.87 0.97
ONPC: optimal number of PCs (see text). EV: explained variance. FNER: fitting-non-error-rate. CVNER:
cross-validation-non-error-rate. ACC: accuracy.
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Contiguous blocks LOO-CV with 19 PCs was applied to a preliminary model in order to select
the optimal number of latent variables to be used for either IC50-PLS-DA or CC50-PLS-DA datasets.
Focusing on IC50-PLS-DA, the analysis of the cross validation error rate (CVER) as a function of the
increasing number of PCs showed a minimum explained variance difference between 7 and 8 PCs,
revealing the first one as the best PC to be used in the final model (Figure 4). A similar analysis was
performed for CC50-PLS-DA, identifying the lowest CVER value both in 1 and the 3 PCs. To guarantee
a major explained variance 3 PC was set (Figure 4).Molecules 2020, 25, x FOR PEER REVIEW 7 of 21 
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the CVER values obtained f r he model built with the number of PCs indicated o the x-axes.
The IC50-PLS-DA model obtained with 7 PCs was characterized by FNER, CVNER and ACC values
of 0.97, 0.85 and 0.87, respectively, dicat ng a good and reli bl classification model. The graphical
inspecti n of the samples class recalcu ation plot of IC50-PLS-DA model revealed quite complete
separation between the wo defin d EO classes ( ctives and non-actives, Figure 5). In particular,
the IC50-PLS-DA classification model recognized al active samples (1, 12, 16, 17 25 and 31) as
actives (green points in Figure 6), nevertheless two onactive samples, namely 15 and 29, were
erroneously recalculated as actives. A high quality and robust CC50-PLS-DA model was instead
obtai d, chara terized by 1.00, 0.97 and 0.97 values of FNER, CVNER and ACC, respectively, being
able to divide the samples in two definite clusters (toxic and non-toxic) with 3 PCs. The CC50-PLS-DA
classification model, obtained ith a cut-off value of 2.06 was able to separate the more toxic samples
(1–4, 6, 9–11, 13–20, 22 and 23) from the less toxic ones (21, 25, 27–38) (Figure 5).
The IC50-PLS-DA and CC50-PLS-DA classification models were also inspected by means of the
features importance plot, in which is summarized the contribution of each chemical constituent to the
biological and toxicology properties, respectively. For the antiviral effects, in the IC50-PLS-DA model
β-myrcene, limonene, 3-octanol and crysanthenone (Figure 7) were characterized by positive PLS
coefficients (Figure 8) that could represent those components able to differentiate EOs into active or
inactive. On the other hand, by inspecting the negative PLS-DA coefficients (Figure 8), these indicated
those compounds likely determining the decreased biological activity. Among those were α-pinene,
α-phellandrene, o-cymene, pulegone, thymol and myristicin (Figure 7). Interestingly, some of these
were pointed by the unsupervised analysis (PCA) as the chemical constituents characterizing the RSEOs
and FVEOs cluster (Figure 3). The only exception was pulegone, associated to negative regression
coefficient, but characterizing the cluster of CNEO samples labeled as active and non-toxic EOs.
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3-metilcicloesanone, germacrene D, isopiperitenone, methylisopulegone, p-menthone, p-menthene
and trans-p-mentha-2,8-dienol had zero values for the PLS-DA coefficient (Figure 7), these molecules
likely to be neutral for the biological activity.
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Figure 5. Separation between active and inactive samples for the binary CC50-PLS-DA classification
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were classified as toxic.
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Among chemical components characterized by negative PLS-DA coefficients, only chrysanthenone
(Figure 7; Figure 9) displayed a highly negative coefficients indicating that it mainly associated to
toxicity, nevertheless chrysanthenone displayed a positive coefficient in the IC50-PLS-DA model.
2.2.3. PLS-DA Classification Models Predictive Abilities
As reported, any quantitative model should be assessed for its effective usability [26]. Herein
the QCAR classification models were tested for their ability to classify the 52 excluded EOs used as
an external test set. The two models were applied in a sequential way, as the first filter, the application
of the above described IC50-PLS-DA classification model, predicted 21 out of 52 samples as potentially
active against HSV-1 (40, 42, 43, 54, 58, 63–69, 72, 74, 75, 78, 79, 83 and 84 of Table 4, Figure 10A). Then,
as a second filter, the CC50-PLS-DA classification model was applied on the 21 predicted active EOs and
predicted only five of them as potentially endowed of low cytotoxicity (68, 73–75 and 79; Figure 10B).
Promptly the five EOs samples 68, 73–75 and 79 were tested both for their ability to inhibit HSV-1
and for their cytotoxicity. Sample 68 was selected as proof of concept as it was predicted to be toxic.
Surprisingly, the experimental data confirmed the predictions, revealing four out of five samples (80%)
to be endowed of high anti-HSV-1 potency and low cytotoxicity. Indeed, two of the newly tested EOs
(73 and 75) displayed IC50 with even greater potencies, being 73 the most potent (IC50 = 0.0632 mg/mL)
and with increased selectivity index (SI = 47.5). In agreement with the prediction, sample 68 was
indeed found with modest anti-HSV-1 potency, quite toxic and low SI index (Table 5).
Table 4. Biological activity classes (IC50 and CC50) of the EOs used as an external test set.
# EO Id a IC50 ClassPredicted
CC50 Class
Predicted # EOs
a IC50 Class
Predicted
CC50 Class
Predicted # EOs
a IC50 Class
Predicted
CC50 Class
Predicted
39 FA1 NA T 57 FSM5 NA T 75 CJM4 A NT
40 FA3 A T 58 FOM1 A T 76 CAM2 NA T
41 FA12 NA T 59 FOM2 NA T 77 CAM4 NA T
42 FA24 A T 60 FOM4 NA T 78 CSM2 A T
43 FS3 A T 61 FOM5 NA T 79 CSM4 A NT
44 FS12 NA T 62 CJ3 A T 80 COM2 NA T
45 FS24 NA T 63 CJ6 A T 81 COM4 NA T
46 FO2 NA T 64 CJ12 A T 82 R1 NA T
47 FO12 NA T 65 CJ24 A T 83 R2 A T
48 FAM1 A T 66 CA12 A T 84 R3 A T
49 FAM2 NA T 67 CA24 A T 85 R12 NA T
50 FAM3 NA T 68 CS12 A T 86 R30 NA T
51 FAM4 NA T 69 CS24 A T 87 RM1 NA T
52 FAM5 NA T 70 CO3 NA T 88 RM2 NA T
53 FSM1 NA T 71 CO12 NA T 89 RM3 NA T
54 FSM2 A T 72 CO24 A T 90 RM5 NA T
55 FSM3 NA T 73 CJM1 A NT
56 FSM4 NA T 74 CJM3 A NT
a EO’s Id refers to that reported in reference [10].
Table 5. Experimental results obtained from biological assays on the predicted samples (see text).
# EO Id a IC50 (mg/mL) CC50 (mg/mL) SI
68 CS12h 0.460 0.520 1.1
73 CJM1 0.063 >3 >47.5
74 CJM3 0.143 2.503 17.5
75 CJM4 0.116 >3 >25.9
79 CSM4 0.124 >3 >24.2
a EO’s Id refers to that reported in reference [10].
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3. Material and Methods
3.1. Plants Materials and EOs Extraction
EOs extracted from Calamintha Nepeta (CNEO), Foeniculum vulgare (FVEO) and Ridolfia Segetum
(RSEO) plants were used in this study. In particular, 38 different EOs were selected from an in-house
list of 90 EOs [10] on the basis of their chemical composition to cover as much as possible the chemical
variability and reducing the experimental part [5,6]. As previously reported [10,27], aerial parts of the
three plants were collected during the summer and early autum periods of the year 2015, in a wild
area around Tarquinia city (Province of Viterbo, Italy). As previously described [27], CNEOs were
obtained directly from fresh plant material, while for FVEOs and RSEOs were used air-dried in a shady
place for 20 days. EOs were extracted by steam distillation using a 62 L distillatory apparatus (Albrigi
Luigi E0131, Verona, Italy), following the protocol previously reported [28]. To prevent degradation
EOs’ were kept frozen at –30 ◦C until their usage and routinely checked for they stability.
EOs were dissolved in ethanol and further diluted in medium for cell culture experiments, always
resulting in an ethanol concentration below 1%, which has no effect on cells and viruses [29].
3.2. GC/MS Analysis
The gas chromatographic/mass spectrometric (GC/MS) EOs analysis protocol was previously
reported [15,27].
3.3. Cell Culture, Virus Production
African green monkey kidney ATCC CCL-81 Vero cells were grown in Roswell Park Memorial
Institute (RPMI) 1640 medium (Gibco, Invitrogen Corporation, CA) supplemented with 10%
heat-inactivated fetal bovine serum (FBS, Gibco, Invitrogen Corporation, CA), 1% glutamine, 50 U
per mL penicillin and 50 µg/mL streptomycin (Sigma–Aldrich, MO, USA). The cells were maintained at
37 ◦C in humidified air containing 5% CO2. Viability of cells was estimated by Trypan blue (0.02% final
concentration) exclusion assay (Invitrogen Corporation). For virus production monolayers of Vero
cells in 75 cm2 tissue culture flasks were infected with HSV-1 strain F at a multiplicity of infection
(m.o.i.) of 0.01. After 48 h at 37 ◦C, infected cells were harvested with 3 freeze-and-thaw cycles, cellular
debris were removed with low-speed centrifugation and the virus titer was measured by the standard
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plaque assay [30]. Similarly, mock solution consists of the supernatant of mock-infected Vero cells.
The titer of the virus preparation was 5 × 108 plaque forming units (pfu)/mL. The virus was stored at
−70 ◦C until used.
3.4. Cellular Toxicity
Cellular toxicity of EOs was tested in vitro, as previously reported [31,32]. Monolayers of
Vero cells were incubated with each of the 38 EOs at concentrations from 0.001 to 0.5 mg/mL
in RPMI 1640 for 24 h and the medium added with 50 µL of a 1 mg/mL solution of MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, Sigma–Aldrich (St. Louis, MO))
in RPMI without phenol red (Sigma–Aldrich). Cells were incubated at 37 ◦C for 3 h, and 100 µL
of acid-isopropanol (0.1 N HCl in isopropanol) was added to each well. After a slightly mixing by
pipetting to ensure that all MTT crystals were dissolved, the plates were read using an automatic plate
reader with a 570 nm test wavelength and a 690 nm reference wavelength. The drug concentration
required for reducing the cell viability by 50% (CC50) was assessed. Wells containing medium with
ethanol at the same concentration as in the samples were also included on each plate as controls.
3.5. In Cell Western (ICW) Technique for Antiviral Activity
The antiviral activity of EOs was evaluated using the in cell western (ICW) technique [33].
Briefly, Vero cells were seeded in 96 well-plates and after 24 h were HSV-1 infected at 0.1 m.o.i. and
after 1 h adsorption at 37 ◦C, the plates were washed with phosphate buffered saline (PBS) and the
medium replaced with 2% FBS RPMI containing 1% glutamine, 50 U per mL penicillin, and 50 µg/mL
streptomycin in the presence of EOs at different serial concentrations (0.50, 0.25, 0.125, 0.0625 and
0.0312 mg/mL). HSV-1-infected cells cultured in the presence of EO vehicle were used as comparative
control. Twenty-four hour later, cells were fixed with 4% paraformaldehyde in PBS for 15 min at room
temperature (r.t.), and then were permeabilized in 0.1% triton X-100 PBS for 5 min at r.t. Cells were then
incubated with Odyssey Blocking Buffer for 1 h at r.t., and then stained 1 h with a primary antibody
raised against glycoprotein B (gB; sc-56987, Santa Cruz, 1:1000 dilution in Odyssey Blocking buffer),
a late HSV-1 protein, then washed three times with PBS containing 0.1% Tween-20 and incubated
with the secondary antibody IRDye 800 CW Goat Anti Mouse (926-32210 LI-COR Biosciences, 1:1000
dilution in Odyssey Blocking buffer; green fluorescence). Finally, cells were stained for 1 h with
Cell-Tag 700 (926-41090, LI-COR Biosciences, 1:500) a fluorescent dye that stains cells and allows one
to detect the cell layer (red fluorescence) in order to normalize viral protein fluorescence intensity to
the cells number. After four washes with PBS containing 0.1% Tween-20, the plate was scanned on
the Odyssey Infrared Imager, and the integrated intensity value of each well read by LI-COR Image
Studio Software developed for Odyssey analysis. Mock-infected cells were used as controls, and their
intensity used as a background. Normalized fluorescence intensity resulting from each staining was
used to evaluate viral replication. Wells containing medium with ethanol at the same concentration as
in the samples were also included on each plate as controls.
3.6. Biological Data Analysis
Data analysis for antiviral activity of EOs by ICW was evaluated using a method developed by
exploiting a Java-based image processing program (IMAGE-J) that allows one to identify the surface
area occupied by fluorescence in each well and then to calculate the ‘area percentage’, i.e., the percentage
of well area covered by fluorescence [34]. The resulting values were fitted by a non-linear regression
using the mathematical model log (EOs) vs. normalized response in GraphPad Prism, (Prism version
6.00 for MS Windows, GraphPad Software, La Jolla California USA, www.graphpad.com). IC50 was
calculated as the drug concentration required for reducing virus replication by 50%.
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3.7. Machine Learning Classification Modeling
MATLAB software, Version 9.1.0 (R2016b; The MathWorks, MA, USA), using PCA Toolbox for
MATLAB (version 1.3; PCA, unsupervised data analysis) and Classification Toolbox for MATLAB
(version 5.0; PLS-DA, supervised data analysis) [35,36] was used for all calculations.
3.7.1. Unsupervised Data Analysis
Chemical composition data was organized in an independent data matrix consisting of 38 rows
(EOs samples) and 56 columns (chemical components). PCA [20] was initially applied as a preliminary
step for exploratory analysis to identify possible outliers. The number of principal components (PCs)
was chosen on the basis of a minimal increment (5%) of explained variance.
3.7.2. Supervised Classification Modeling
For the binary classification models [22], performed with PLS-DA [37], the EOs concentrations,
used as the independent variable X matrix, were pretreated by means of a mean scaling. The PLS-DA
technique is a special form of projection of latent structures (PLS, also named partial least square)
commonly used for linear classification [38] that search for latent variables with a maximum covariance
with the Y variables. In PLS-DA the Y-block describes which objects are in the defined classes.
In a binary classification application, the continuous variable can be easily defined in two classes by
a cutoff value and setting the values to 1 if the objects have Y higher values than the cutoff and 0
if they are lower [39]. Elaboration of the model will return calculated Y values, in a similar way as
for a regression approach by PLS. In analogy with the PLS algorithm, the model is described by the
variables regression, i.e., for each class. PLS coefficients characterized by high absolute values are
generally related to important variables for class discrimination, in particular positive coefficients
indicate those variables that most contribute to the increase of the 1 class calculated response [35].
The coefficients were used to elaborate the feature importance plot (see the Results and Discussion
Section Figures 7 and 8).
The antiviral activity (IC50) and the toxicity (CC50; Table 2) values experimentally determined
were used as dependent variable vectors in two distinct PLS-DA models in which each dependent
variable was divided into two classes (active/non-active and toxic/non-toxic) on the basis of an optimal
cut-off value (see results section) obtained by a systematic procedure search. The final classification
models were numerically and graphically evaluated through explained variance, accuracy (ACC) and
non-error rate (NER) [40] as calculated from the final model and leave-one-out cross internal validation.
The accuracy describes the global predictive ability, identifying as positive the true positive and
as negative the true negative and is defined as:
ACC =
∑G
g = 1ng
n
where n is the total number of samples. Not assigned samples are not considered for the
accuracy calculation.
The NER [29] was calculated as arithmetic mean of sensitivity values of the G classes.
NER =
∑G
g = 1Sng
G
where G is the total number of classes, and Sng [40] is the sensitivity of the g-th class, also known as
true positive rate, and can be defined as the ability of given classifier to correctly identify the samples
of the g-th class and can be calculated as:
Sng =
cgg
ng
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where cgg is the number of samples belonging and correctly assigned to class g and ng is the number of
samples belonging to the g-th class. In the text a reference was added for this concept.
3.8. Assessment of the Models’ Predictive Ability
An internal library of 52 EOs samples not used to define the PLS-DA model was selected as the
external test set. The chemical composition of the test set was known and organized in an independent
data matrix similarly as for the training set and consisted of 52 rows (EOs samples) and 56 columns
(chemical components) [27].
4. Conclusions
From an internal library of 90 different EOs a training set of 38 was compiled, tested for antiviral
activity and cytotoxicity and the experimental data used to develop PLS-DA classification models able
to discriminate either anti-HSV-1 active versus non active samples or cytotoxic versus low cytotoxic
endowed samples. Two classification models were obtained with satisfactory statistical coefficients.
Analysis of the models by means of features importance indicated β-myrcene, limonene 3-octanol and
chrysanthenone as key chemical components for the EOs’ biological effects. The two models were
applied to EOs not included in the training set and proved their predictive abilities in selecting five
EOs capable of high antiviral potency and low cytotoxicity. Four out of five (80%) of the selected EOs
indeed revealed to be active against HSV-1 and with low cytotoxicity values.
These results and those previously reported demonstrating the EOs great antioxidant and
antimicrobial properties [41], confirm the possibility of using these substances in a wide array of
applications, like pharmaceutical [11], nutraceutical [42] and food preservatives [43]. Despite the
wide EOs potential, further efforts are needed to better understand crucial-chemical information like
optimum dose and safe limits, as well as aspects related to food uses, as the impact of these compounds
on sensory quality.
Different interesting aspects to be clarified and deepened is how the chemical composition may
influence the observed biological effects, if these are the results of possible synergistic or antagonistic
mechanisms between the single chemical components and if the isolated compound preserves the same
identified effects. Several reports with this purpose have been found in the literature, often enriched
with extensive machine learning approaches [11] in which a potential main chemical compound
was identified and investigated about its biological properties [44]. This latter step is crucial for the
detection of new molecules able to replace and support those already known and used as antimicrobial
and antifungal agents. In this context are important further extensive researches trying to model
blended EOs with enhanced biological profiles and mix key chemical components for preparation of
mixture with ad-hoc enhanced efficacy and less toxicity.
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